Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 3,182,000 | 3,706,000 | 3,096,000 | 730,000 | 1,735,000 |
Marketable Securities | 23,270,000 | 25,257,000 | 22,388,000 | 23,279,000 | 26,277,000 |
Receivables | 13,058,000 | 15,749,000 | 15,192,000 | 15,182,000 | 13,380,000 |
Inventories | 6,610,000 | 8,426,000 | 8,597,000 | 8,467,000 | 8,275,000 |
Other current assets | 14,697,000 | 9,594,000 | 11,211,000 | 10,586,000 | 11,346,000 |
TOTAL | $60,817,000 | $62,732,000 | $60,484,000 | $58,244,000 | $61,013,000 |
Non-Current Assets | |||||
PPE Net | 15,921,000 | 17,721,000 | 18,281,000 | 18,833,000 | 18,645,000 |
Investments And Advances | 9,814,000 | 9,468,000 | 10,207,000 | 9,811,000 | 9,747,000 |
Intangibles | 95,753,000 | 101,006,000 | 102,166,000 | 103,350,000 | 101,483,000 |
Other Non-Current Assets | 5,697,000 | 5,205,000 | 4,761,000 | 4,718,000 | 4,126,000 |
TOTAL | $127,185,000 | $133,400,000 | $135,415,000 | $136,712,000 | $134,001,000 |
Total Assets | $188,002,000 | $196,132,000 | $195,899,000 | $194,956,000 | $195,014,000 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 4,016,000 | 5,637,000 | 5,988,000 | 6,093,000 | 5,603,000 |
Accounts payable and accrued liabilities | 3,678,000 | 3,765,000 | 3,698,000 | 3,750,000 | 3,994,000 |
Accrued Expenses | 2,120,000 | 1,999,000 | 1,815,000 | 1,849,000 | 2,080,000 |
Other current liabilities | 15,066,000 | 14,240,000 | 15,303,000 | 15,338,000 | 14,256,000 |
TOTAL | $28,909,000 | $27,856,000 | $30,471,000 | $29,171,000 | $28,636,000 |
Non-Current Liabilities | |||||
Long Term Debt | 34,926,000 | 35,399,000 | 35,723,000 | 35,308,000 | 38,410,000 |
Other Non-Current Liabilities | 22,676,000 | 21,921,000 | 20,662,000 | 20,518,000 | 21,068,000 |
TOTAL | $76,472,000 | $77,746,000 | $76,465,000 | $75,252,000 | $78,113,000 |
Total Liabilities | $105,381,000 | $105,602,000 | $106,936,000 | $104,423,000 | $106,749,000 |
Shareholders' Equity | |||||
Shares Outstanding, K | 7,538,520 | 7,686,967 | 7,802,127 | 7,901,130 | 7,995,220 |
Common Shares | 445,000 | 445,000 | 445,000 | 444,000 | 444,000 |
Retained earnings | 46,210,000 | 48,121,000 | 44,320,000 | 44,926,000 | 42,716,000 |
Other shareholders' equity | -3,656,000 | -685,000 | -426,000 | -1,547,000 | -2,943,000 |
TOTAL | $82,621,000 | $90,530,000 | $88,963,000 | $90,533,000 | $88,265,000 |
Total Liabilities And Equity | $188,002,000 | $196,132,000 | $195,899,000 | $194,956,000 | $195,014,000 |